Jefferies Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-21,618
| Closed | -$4.69M | – | 2185 |
|
|
2021
Q1 | $4.69M | Sell |
21,618
-37,491
| -63% | -$7.05M | 0.04% | 401 |
|
|
2020
Q4 | $6.82M | Sell |
59,109
-35,726
| -38% | -$4M | 0.05% | 313 |
|
|
2020
Q3 | $9.23M | Buy |
94,835
+38,051
| +67% | +$4.38M | 0.1% | 163 |
|
|
2020
Q2 | $6.97K | Sell |
56,784
-71,522
| -56% | -$8.11M | 0.08% | 207 |
|
|
2020
Q1 | $11.2M | Buy |
128,306
+68,877
| +116% | +$7.29M | 0.12% | 137 |
|
|
2019
Q4 | $6.21M | Buy |
59,429
+20,219
| +52% | +$2.27M | 0.05% | 422 |
|
|
2019
Q3 | $4.51M | Sell |
39,210
-2,314
| -6% | -$351K | 0.04% | 575 |
|
|
2019
Q2 | $7.16M | Buy |
41,524
+13,540
| +48% | +$2.34M | 0.05% | 323 |
|
|
2019
Q1 | $4.72M | Buy |
27,984
+10,759
| +62% | +$1.6M | 0.04% | 464 |
|
|
2018
Q4 | $1.68M | Buy |
17,225
+14,778
| +604% | +$1.94M | 0.01% | 902 |
|
|
2018
Q3 | $423K | Sell |
2,447
-4,470
| -65% | -$645K | ﹤0.01% | 1702 |
|
|
2018
Q2 | $965K | Buy |
+6,917
| New | +$983K | 0.01% | 1292 |
|
|
2017
Q2 | – | Sell |
-2,800
| Closed | -$339K | – | 2714 |
|
|
2017
Q1 | $339K | Buy |
+2,800
| New | +$343K | ﹤0.01% | 1766 |
|
|
2016
Q2 | – | Sell |
-2,300
| Closed | -$194K | – | 2541 |
|
|
2016
Q1 | $166K | Buy |
+2,300
| New | +$126K | ﹤0.01% | 1886 |
|
Other funds holding GWPH
Jefferies Group's GWPH Position: Q2 2021 in Review
Jefferies Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 21,618 shares — an estimated $4.69M sold.
Jefferies Group first reported a position in GWPH in Q1 2016 and held it in 14 quarters. The position peaked at $11.2M in Q1 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Jefferies Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Jefferies Group sold 21,618 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.69M.
- Jefferies Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 14 quarters.
- Jefferies Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11.2M in Q1 2020.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.